Search reports.
Bronchitis Treatment Market Size, Share & Growth Report 2030
Get free sample report Request for Customiztion Buy Now

Bronchitis Treatment Market Size, Share & Growth Report 2030

Segments - Bronchitis Treatment Market by Treatments (Oxygen Therapy and Drugs), Drugs Class (Anti-inflammatory Drugs, Antibiotics, Mucolytics, and Bronchodilators), End-users (Hospitals, Clinics, and Drug Stores), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-2355 | 4.2 Rating | 82 Reviews | 140 Pages | Format : PDF Excel PPT

Report Description


The global bronchitis treatment market size is estimated to register a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the large patient control and increasing competitive activities of advancement of bronchitis treatment products.

Bronchitis refers to festering of the bronchial tubes that provide air to the lungs. Some other symptoms are wheezing, shortness of breath, low fever, and tight chest; among these cough with mucus is found to be a common condition of the patient suffering from the disorder. It is a respiratory disease where inflammation occurs of the bronchi within lungs.

Global Bronchitis Treatment Market Key Takeaways

The restraining elements that accelerate the chances of bronchitis are gastric reflux, cigarette smoking, and exposure to irritants during work such as chemicals, dust, and fumes. Additionally, it is most common that it usually occurs when the infection is becoming very intense into the lungs. This infection is the reason of air sacs in the lungs, which is filled with fluid.

The two types of bronchitis are acute bronchitis and chronic bronchitis. Acute bronchitis is a temporary condition of the disease infection in the lungs, which is also called as a chest cold. Most of the cases of acute bronchitis are caused by viruses and some of the most common symptom of acute bronchitis are fever, cough, wheezing, and shortness of breath. Meanwhile, chronic bronchitis, also known as chronic obstructive pulmonary disease, is a prolonged and long–term disease infection in the lungs. It is caused by airway tissue, damage to the lung and repeated irritation.

  • Presence of a large pool of the targeted patients globally due to unhealthy habits such as smoking presents a key driver of the market.
  • Rising level of chemical pollutants in the air and increasing cases of lung infections worldwide are some major factors boosting the market growth.
  • Wide availability of advanced treatment for bronchitis and lungs infections are expected to fuel the market growth.
  • Establishment of well-equipped healthcare infrastructure and facilities for the chronic disease treatment is driving the market expansion.
  • Increasing drugs patent expiry for the disease treatment is expected to hamper the growth of the market.

Scope of Bronchitis Treatment Market Report

The report on the global bronchitis treatment market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Bronchitis Treatment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Treatments (Drugs and Oxygen Therapy), Drugs Class (Antibiotics, Anti-inflammatory Drugs, Bronchodilators, and Mucolytics), End-users (Hospitals, Clinics, and Drug Stores)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Boehringer Ingelheim; Dr. Reddy’s Laboratories Ltd; GlaxoSmithKline Pharmaceuticals Limited; Pfizer Inc.; and Sanofi Aventis.

Bronchitis Treatment Market Segment Insights

Drugs segment is expected to grow at a rapid pace

Based on treatments, the global bronchitis treatment market is bifurcated into oxygen therapy and drugs. The drugs segment accounted for a key share of the market in 2020 and is expected to grow at a rapid pace during the projected period due to advancement in the drug manufacturing technology. However, the oxygen therapy segment is anticipated to expand at a significant growth rate during the forecast period owing to increase in the adoption rate of the therapy for the particular disease treatment.

Antibiotics segment is projected to expand at a considerable CAGR

On the basis of drugs class, the market is divided into bronchodilators, anti-inflammatory drugs, bronchodilators, antibiotics, and mucolytics. The antibiotics segment is projected to expand at a considerable CAGR during the forecast period owing to low cost and easy availability of the drug type. Meanwhile, the mucolytics segment is anticipated to represent a healthy growth rate during the forecast period due to increasing demand for the drug among patients.

Global Bronchitis Treatment Market Drugs Class

Hospitals segment is expected to exhibit a robust growth rate

Based on end-users, the global bronchitis treatment market is segmented into drug stores, clinics, and hospitals. The hospitals segment held a dominant share of the market in 2019 and is expected to exhibit a robust growth rate in the coming years due to large number of increasing chronic diseases and frequent hospital visit by patients for the treatment. On the other hand, the clinics part is anticipated to hold a large market share during the projected period owing to rapid expansion of several clinics facilitating easy access at low cost.

North America is anticipated to constitute a key market share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the forecast period due to increasing number of patients and rapid adoption of advanced treatment methods for various diseases in the region. The market of Asia Pacific, however, is expected to register a substantial growth rate in the coming years owing to increasing healthcare infrastructure and facilities under several governments’ initiatives in the region.

Global Bronchitis Treatment Market Regions

Segments

The global bronchitis treatment market has been segmented on the basis of

Treatments

  • Drugs
  • Oxygen Therapy

Drugs Class

  • Antibiotics
  • Anti-inflammatory Drugs
  • Bronchodilators
  • Mucolytics

End-users

  • Hospitals
  • Clinics
  • Drug Stores

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

Competitive Landscape

Key players competing in the global bronchitis treatment market are Boehringer Ingelheim; Dr. Reddy’s Laboratories Ltd; GlaxoSmithKline Pharmaceuticals Limited; Pfizer Inc.; and Sanofi Aventis. These main market players are continuously engaged in various business development activities such as mergers, acquisitions, research and developments, investments for innovative products, and collaborations to expand their business operations and widen their geographical reach.

Global Bronchitis Treatment Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Bronchitis Treatment Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Bronchitis Treatment Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Bronchitis Treatment Market - Supply Chain
  4.5. Global Bronchitis Treatment Market Forecast
     4.5.1. Bronchitis Treatment Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Bronchitis Treatment Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Bronchitis Treatment Market Absolute $ Opportunity
5. Global Bronchitis Treatment Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Bronchitis Treatment Market Size and Volume Forecast by End Users
     5.3.1. Hospitals Clinics Drug Stores
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Bronchitis Treatment Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Bronchitis Treatment Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Bronchitis Treatment Demand Share Forecast, 2019-2026
7. North America Bronchitis Treatment Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Bronchitis Treatment Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Bronchitis Treatment Market Size and Volume Forecast by End Users
     7.4.1. Hospitals Clinics Drug Stores
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Bronchitis Treatment Demand Share Forecast, 2019-2026
8. Latin America Bronchitis Treatment Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Bronchitis Treatment Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Bronchitis Treatment Market Size and Volume Forecast by End Users
     8.4.1. Hospitals Clinics Drug Stores
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Bronchitis Treatment Demand Share Forecast, 2019-2026
9. Europe Bronchitis Treatment Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Bronchitis Treatment Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Bronchitis Treatment Market Size and Volume Forecast by End Users
     9.4.1. Hospitals Clinics Drug Stores
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Bronchitis Treatment Demand Share Forecast, 2019-2026
10. Asia Pacific Bronchitis Treatment Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Bronchitis Treatment Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Bronchitis Treatment Market Size and Volume Forecast by End Users
     10.4.1. Hospitals Clinics Drug Stores
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Bronchitis Treatment Demand Share Forecast, 2019-2026
11. Middle East & Africa Bronchitis Treatment Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Bronchitis Treatment Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Bronchitis Treatment Market Size and Volume Forecast by End Users
     11.4.1. Hospitals Clinics Drug Stores
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Bronchitis Treatment Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Bronchitis Treatment Market: Market Share Analysis
  12.2. Bronchitis Treatment Distributors and Customers
  12.3. Bronchitis Treatment Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Boehringer Ingelheim Dr. Reddy’s Laboratories Ltd GlaxoSmithKline Pharmaceuticals Limited Pfizer Inc. Sanofi Aventis

Methodology

Our Clients

Pfizer
Honda Motor Co. Ltd.
General Mills
Microsoft
Deloitte
sinopec
Nestle SA
General Electric